MARKET WIRE NEWS
  1. Home
  2. Stock
  3. AARD
  4. News
AARD
Quote
Short
News
Articles
Message Board

Aardvark Therapeutics Inc. (NASDAQ : AARD ) News

Aardvark Therapeutics Inc. (NASDAQ: AARD) News Releases

AARD News Releases
AARD : NASDAQ
PR Newswire
Aardvark Therapeutics (AARD) Faces Investor Scrutiny Amid 56% Drop On Clinical Pause For Lead Drug Candidate- HBSS
AARD : NASDAQ
SeekingAlpha
Aardvark Therapeutics: Regulatory Uncertainty Clouds ARD-101 Path Forward
AARD : NASDAQ
SeekingAlpha
Aardvark plummets on FDA clinical hold on Prader-Willi Syndrome asset
AARD : NASDAQ
KlickAnalytics
Buy Recommendation Issued On AARD By B. Riley
AARD : NASDAQ
GlobeNewswire
Aardvark Therapeutics Plans to Unblind HERO and OLE Data to Inform Path Forward Following FDA Clinical Hold
AARD : NASDAQ
SeekingAlpha
Aardvark Therapeutics GAAP EPS of -$0.99
AARD : NASDAQ
GlobeNewswire
Aardvark Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
AARD : NASDAQ
PR Newswire
Aardvark Therapeutics (AARD) Faces Investor Scrutiny Amid 56% Drop On Clinical Pause For Lead Drug Candidate- Hagens Berman
AARD : NASDAQ
SeekingAlpha
Aardvark Therapeutics GAAP EPS of -$0.81 beats by $0.02
AARD : NASDAQ
GlobeNewswire
Aardvark Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.